Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group

Table 3

HBsAg status in newborns.

Groups	Cases	HBsAg+ cases at birth	HBsAg+ cases 24 weeks after birth
Telbivudine group	60	2	0^#
Tenofovir group	60	1	0^#
Lamivudine group	60	1	0^#
HBIG group	30	4	3^#
Control group	28	12	11

^#Statistical significance compared with the control group, . Statistical significance compared with the HBIG group, .